Why is Definium Therapeutics, Inc. stock up today?
August 9, 2026
Definium Therapeutics, Inc.
DFTX · NMS · USD
vs. prev. close $46.14
Last updated Aug 7, 2026 20:00
Intraday Chart — 5-min intervals
DFTX · less than a minute ago
Definium Therapeutics, Inc. edges higher 0.00% — GuruFocus.com reports
Definium Therapeutics, Inc. (DFTX) is holding steady with a slight gain, at $46. 14 — up 0. 00% from yesterday's close of $46. 14. Today's move appears driven by recent headlines, including "Definium Therapeutics Inc (DFTX) (Q2 2026) Earnings Call Highlights: Record Phase III MDD ... " and "Definium Therapeutics Q2 Earnings Call Highlights". News sentiment around DFTX is leaning mixed.
The broader market is under pressure (S&P 500: +0. 6%, Nasdaq: +1. 3%, Dow Jones: +0. 3%, Shanghai: +1. 0%, Hang Seng: +0. 5%). Past performance does not guarantee future results.
Key Factors
Auto-generated analysis · Not financial advice
Definium Therapeutics Inc (DFTX) (Q2 2026) Earnings Call Highlights: Record Phase III MDD ...
GuruFocus.com·2 days agoneutralDefinium Therapeutics Q2 Earnings Call Highlights
MarketBeat·2 days agoneutralDefinium Therapeutics Q2 Loss Widens
MT Newswires·2 days agoneutralDefinium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Business Wire·2 days agoneutralDefinium Therapeutics Announces New Employee Inducement Grants
Business Wire·5 days agoneutralWall Street Analysts See a 34.86% Upside in Definium Therapeutics, Inc. (DFTX): Can the Stock Really Move This High?
Zacks·8 days agoneutralDefinium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Wire·9 days agoneutralDefinium Therapeutics (DFTX) Redefines Depression & Anxiety Treatment
Insider Monkey·9 days agoneutral
S&P 500
+0.62%
Nasdaq
+1.30%
Dow Jones
+0.28%
Shanghai
+1.02%
Hang Seng
+0.54%
Nikkei 225
-0.12%
FTSE 100
+0.31%
Nifty 50
-0.27%
DAX
+0.69%
OMX Stockholm
-0.32%
Search another stock